The Associations of Selenoprotein Genetic Variants with the Risks of Colorectal Adenoma and Colorectal Cancer: Case-Control Studies in Irish and Czech Populations.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
29 Jun 2022
Historique:
received: 09 06 2022
accepted: 27 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Selenium manifests its biological effects through its incorporation into selenoproteins, which play several roles in countering oxidative and inflammatory responses implicated in colorectal carcinogenesis. Selenoprotein genetic variants may contribute to colorectal cancer (CRC) development, as we previously observed for SNP variants in a large European prospective study and a Czech case-control cohort. We tested if significantly associated selenoprotein gene SNPs from these studies were also associated with CRC risk in case-control studies from Ireland (colorectal neoplasia, i.e., cancer and adenoma cases: 450, controls: 461) and the Czech Republic (CRC cases: 718, controls: 646). Genotyping of 23 SNPs (20 in the Irish and 13 in the Czechs) was performed by competitive specific allele-specific PCR (KASPar). Multivariable adjusted logistic regression was used to assess the associations with CRC development. We found significant associations with an increased CRC risk for rs5859 ( Several SNPs previously associated with CRC risk were also associated with CRC or colorectal neoplasia development in either the Irish or Czech cohorts. Selenoprotein gene variation may modify CRC risk across diverse European populations, although the specific variants may differ.

Sections du résumé

BACKGROUND BACKGROUND
Selenium manifests its biological effects through its incorporation into selenoproteins, which play several roles in countering oxidative and inflammatory responses implicated in colorectal carcinogenesis. Selenoprotein genetic variants may contribute to colorectal cancer (CRC) development, as we previously observed for SNP variants in a large European prospective study and a Czech case-control cohort.
METHODS METHODS
We tested if significantly associated selenoprotein gene SNPs from these studies were also associated with CRC risk in case-control studies from Ireland (colorectal neoplasia, i.e., cancer and adenoma cases: 450, controls: 461) and the Czech Republic (CRC cases: 718, controls: 646). Genotyping of 23 SNPs (20 in the Irish and 13 in the Czechs) was performed by competitive specific allele-specific PCR (KASPar). Multivariable adjusted logistic regression was used to assess the associations with CRC development.
RESULTS RESULTS
We found significant associations with an increased CRC risk for rs5859 (
CONCLUSIONS CONCLUSIONS
Several SNPs previously associated with CRC risk were also associated with CRC or colorectal neoplasia development in either the Irish or Czech cohorts. Selenoprotein gene variation may modify CRC risk across diverse European populations, although the specific variants may differ.

Identifiants

pubmed: 35807897
pii: nu14132718
doi: 10.3390/nu14132718
pmc: PMC9268344
pii:
doi:

Substances chimiques

Selenoprotein P 0
Selenoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Health Research Board of Ireland
ID : HRA-POS/2013/397
Organisme : International Hundred K+ Cohorts Consortium/Global Genomic Medicine Collaborative (IHCC/G2MC)
ID : 31312020
Organisme : Czech Science Foundation
ID : GACR 20-03997S
Organisme : Czech Science Foundation
ID : VV 22-05942S
Organisme : Czech Health Research council of the Ministry of Health of the Czech Republic
ID : AZV NV18-03-00199

Références

Annu Rev Nutr. 2008;28:157-77
pubmed: 18494599
PLoS One. 2012;7(5):e37312
pubmed: 22615972
Free Radic Biol Med. 2018 Nov 1;127:14-25
pubmed: 29793041
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1822-30
pubmed: 21765007
Biochem J. 2009 Jul 29;422(1):11-22
pubmed: 19627257
Free Radic Biol Med. 2020 Nov 20;160:670-679
pubmed: 32846216
Cancer Res. 2002 Sep 15;62(18):5325-35
pubmed: 12235003
Biochem J. 2016 Jul 15;473(14):2141-54
pubmed: 27208177
Genes Nutr. 2010 Sep;5(3):215-23
pubmed: 21052528
Sci Total Environ. 2005 Feb 15;338(3):183-8
pubmed: 15713327
Genes Nutr. 2007 Nov;2(2):225-32
pubmed: 18850177
Genes Chromosomes Cancer. 2012 Jun;51(6):598-605
pubmed: 22371331
Mol Aspects Med. 2019 Oct;69:2-9
pubmed: 31233770
Nutrients. 2015 Mar 31;7(4):2209-36
pubmed: 25835046
Carcinogenesis. 2008 Mar;29(3):579-84
pubmed: 18192692
Colorectal Dis. 2013 Sep;15(9):e512-21
pubmed: 23746062
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Annu Rev Nutr. 2005;25:215-35
pubmed: 16011466
Nutrients. 2015 May 15;7(5):3621-51
pubmed: 25988760
Clin Gastroenterol Hepatol. 2004 Jan;2(1):1-8
pubmed: 15017625
Nucleic Acids Res. 1995 Dec 11;23(23):4878-84
pubmed: 8532532
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1144-54
pubmed: 18483336
Nutrients. 2018 Nov 21;10(11):
pubmed: 30469315
Trends Biochem Sci. 2014 Mar;39(3):112-20
pubmed: 24485058
Cancer Treat Res. 2014;159:145-66
pubmed: 24114479
Antioxid Redox Signal. 2011 Apr 1;14(7):1337-83
pubmed: 20812787
Biochim Biophys Acta. 2009 Nov;1790(11):1533-40
pubmed: 19327385
Hum Mol Genet. 2003 May 1;12(9):1045-53
pubmed: 12700173
Carcinogenesis. 2010 Jun;31(6):1074-9
pubmed: 20378690
AJR Am J Roentgenol. 2007 Apr;188(4):940-4
pubmed: 17377027
Glycobiology. 2014 Apr;24(4):344-50
pubmed: 24415556
Biochim Biophys Acta. 2009 Nov;1790(11):1453-62
pubmed: 19328222
Genet Test Mol Biomarkers. 2020 Dec;24(12):835-844
pubmed: 33290140
Br J Nutr. 2008 Aug;100(2):254-68
pubmed: 18346308
Mutagenesis. 2012 Mar;27(2):177-86
pubmed: 22294765
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Protoc. 2011 Feb;6(2):121-33
pubmed: 21293453
N Engl J Med. 2014 Apr 3;370(14):1298-306
pubmed: 24693890
Nat Genet. 2005 Nov;37(11):1234-41
pubmed: 16227999
Gut. 2003 Aug;52(8):1140-7
pubmed: 12865272
Carcinogenesis. 2021 Apr 17;42(3):378-394
pubmed: 33319241
Int J Cancer. 2015 Mar 1;136(5):1149-61
pubmed: 25042282
Nutrients. 2019 Apr 25;11(4):
pubmed: 31027226
Prostate. 2018 Mar;78(4):279-288
pubmed: 29314169

Auteurs

Maryam Mukhtar (M)

Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.

Niall Ashfield (N)

Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.

Ludmila Vodickova (L)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic.

Veronika Vymetalkova (V)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic.

Miroslav Levy (M)

Department of Surgery, First Faculty of Medicine, Charles University and Thomayer Hospital, 121 08 Prague, Czech Republic.

Václav Liska (V)

Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.

Jan Bruha (J)

Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic.

Petra Bendova (P)

Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic.

Jacintha O'Sullivan (J)

Trinity Translational Medicine Institute, Department of Surgery, Trinity College Dublin and St. James's Hospital, D08 NHY1 Dublin, Ireland.

Glen Doherty (G)

Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.

Kieran Sheahan (K)

Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.

Blathnaid Nolan (B)

Centre for Colorectal Disease, St. Vincent's University Hospital, D04 T6F4 Dublin, Ireland.

Pavel Vodicka (P)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Institute of Experimental Medicine ASCR, 142 20 Prague, Czech Republic.

David J Hughes (DJ)

Cancer Biology and Therapeutics Group, School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH